LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 145

Search options

  1. Article ; Online: Improving "may contain" labels: A call to team up and share data.

    Turner, Paul J / Eiwegger, Thomas

    Allergy

    2024  

    Language English
    Publishing date 2024-01-12
    Publishing country Denmark
    Document type Editorial
    ZDB-ID 391933-x
    ISSN 1398-9995 ; 0105-4538
    ISSN (online) 1398-9995
    ISSN 0105-4538
    DOI 10.1111/all.16012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Defining the questions to be asked in severe asthma trials: data from the COMSA working group.

    Eiwegger, Thomas / Bendien, Sarah A

    The European respiratory journal

    2023  Volume 61, Issue 4

    MeSH term(s) Humans ; Child ; Adult ; Asthma/drug therapy ; Outcome Assessment, Health Care
    Language English
    Publishing date 2023-04-03
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 639359-7
    ISSN 1399-3003 ; 0903-1936
    ISSN (online) 1399-3003
    ISSN 0903-1936
    DOI 10.1183/13993003.02058-2022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Introducing peanut early in life - Ready for the general population?

    Szépfalusi, Zsolt / Eiwegger, Thomas

    Allergy

    2023  Volume 78, Issue 5, Page(s) 1142–1144

    MeSH term(s) Humans ; Arachis/adverse effects ; Peanut Hypersensitivity/diagnosis ; Peanut Hypersensitivity/epidemiology ; Desensitization, Immunologic
    Language English
    Publishing date 2023-03-30
    Publishing country Denmark
    Document type Editorial
    ZDB-ID 391933-x
    ISSN 1398-9995 ; 0105-4538
    ISSN (online) 1398-9995
    ISSN 0105-4538
    DOI 10.1111/all.15676
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: An alternative path to oral tolerance.

    Li, Carmen H / Kabak, Ekaterina / Eiwegger, Thomas

    Allergy

    2023  Volume 78, Issue 7, Page(s) 2058–2060

    MeSH term(s) Humans ; Food Hypersensitivity ; Dendritic Cells ; Immune Tolerance ; Allergens ; Administration, Oral ; T-Lymphocytes, Regulatory
    Chemical Substances Allergens
    Language English
    Publishing date 2023-03-16
    Publishing country Denmark
    Document type News
    ZDB-ID 391933-x
    ISSN 1398-9995 ; 0105-4538
    ISSN (online) 1398-9995
    ISSN 0105-4538
    DOI 10.1111/all.15701
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Avoiding avoidance in milk and egg allergy.

    Wong, Dennis / Eiwegger, Thomas / Upton, Julia E M

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

    2022  Volume 129, Issue 6, Page(s) 657–658

    MeSH term(s) Humans ; Animals ; Egg Hypersensitivity ; Milk
    Language English
    Publishing date 2022-12-01
    Publishing country United States
    Document type Editorial ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 1228189-x
    ISSN 1534-4436 ; 0003-4738 ; 1081-1206
    ISSN (online) 1534-4436
    ISSN 0003-4738 ; 1081-1206
    DOI 10.1016/j.anai.2022.09.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Oral immunotherapy for food allergy: What's age got to do with it?

    Upton, Julia E M / Correa, Natasha / Eiwegger, Thomas

    Allergy

    2022  Volume 78, Issue 3, Page(s) 626–628

    MeSH term(s) Humans ; Food Hypersensitivity/therapy ; Anaphylaxis/drug therapy ; Immunotherapy ; Allergens/therapeutic use ; Desensitization, Immunologic ; Administration, Oral
    Chemical Substances Allergens
    Language English
    Publishing date 2022-12-21
    Publishing country Denmark
    Document type Editorial
    ZDB-ID 391933-x
    ISSN 1398-9995 ; 0105-4538
    ISSN (online) 1398-9995
    ISSN 0105-4538
    DOI 10.1111/all.15623
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Management of allergic diseases in pregnancy.

    Pfaller, Birgit / Bendien, Sarah / Ditisheim, Agnès / Eiwegger, Thomas

    Allergy

    2021  Volume 77, Issue 3, Page(s) 798–811

    Abstract: Allergic diseases like asthma, allergic rhinitis, food allergy, hymenoptera allergy, or atopic dermatitis are highly prevalent in women of childbearing age and may affect up to 30% of this age group. This review focuses on the management of allergic ... ...

    Abstract Allergic diseases like asthma, allergic rhinitis, food allergy, hymenoptera allergy, or atopic dermatitis are highly prevalent in women of childbearing age and may affect up to 30% of this age group. This review focuses on the management of allergic diseases during pregnancy. Furthermore, we discuss the challenges of counseling women with allergic diseases in the reproductive age, including considerations relevant to the ongoing SARS-CoV-2 pandemic. To create the optimal milieu for the unborn child, a multitude of immunological changes occur during pregnancy which may favor type 2 responses and aggravate disease phenotypes. In co-occurrence with suboptimal preconception disease control, this elevated Th2 responses may aggravate allergic disease manifestations during pregnancy and pose a risk for mother and child. Due to limitations in conducting clinical trials in pregnant women, safety data on anti-allergic drugs during pregnancy are limited. The lack of information and concerns among pregnant patients demands counseling on the benefits of anti-allergic drugs and the potential and known risks. This includes information on the risk for mother and child of disease aggravation in the absence of treatment. By doing so, informed decisions and shared decision-making can take place.
    MeSH term(s) COVID-19 ; Dermatitis, Atopic ; Female ; Food Hypersensitivity ; Humans ; Pregnancy ; Rhinitis, Allergic ; SARS-CoV-2
    Language English
    Publishing date 2021-09-04
    Publishing country Denmark
    Document type Journal Article ; Review
    ZDB-ID 391933-x
    ISSN 1398-9995 ; 0105-4538
    ISSN (online) 1398-9995
    ISSN 0105-4538
    DOI 10.1111/all.15063
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: An update on recent developments and highlights in food allergy.

    Locke, Arielle / Hung, Lisa / Upton, Julia E M / O'Mahony, Liam / Hoang, Jennifer / Eiwegger, Thomas

    Allergy

    2023  Volume 78, Issue 9, Page(s) 2344–2360

    Abstract: While both the incidence and general awareness of food allergies is increasing, the variety and clinical availability of therapeutics remain limited. Therefore, investigations into the potential factors contributing to the development of food allergy (FA) ...

    Abstract While both the incidence and general awareness of food allergies is increasing, the variety and clinical availability of therapeutics remain limited. Therefore, investigations into the potential factors contributing to the development of food allergy (FA) and the mechanisms of natural tolerance or induced desensitization are required. In addition, a detailed understanding of the pathophysiology of food allergies is needed to generate compelling, enduring, and safe treatment options. New findings regarding the contribution of barrier function, the effect of emollient interventions, mechanisms of allergen recognition, and the contributions of specific immune cell subsets through rodent models and human clinical studies provide novel insights. With the first approved treatment for peanut allergy, the clinical management of FA is evolving toward less intensive, alternative approaches involving fixed doses, lower maintenance dose targets, coadministration of biologicals, adjuvants, and tolerance-inducing formulations. The ultimate goal is to improve immunotherapy and develop precision-based medicine via risk phenotyping allowing optimal treatment for each food-allergic patient.
    MeSH term(s) Humans ; Food Hypersensitivity/therapy ; Food ; Peanut Hypersensitivity ; Allergens ; Immunotherapy ; Desensitization, Immunologic
    Chemical Substances Allergens
    Language English
    Publishing date 2023-05-12
    Publishing country Denmark
    Document type Journal Article ; Review
    ZDB-ID 391933-x
    ISSN 1398-9995 ; 0105-4538
    ISSN (online) 1398-9995
    ISSN 0105-4538
    DOI 10.1111/all.15749
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: An update on recent developments and highlights in food allergy

    Locke, Arielle / Hung, Lisa / Upton, Julia E. M. / O'Mahony, Liam / Hoang, Jennifer / Eiwegger, Thomas

    Allergy. 2023 Sept., v. 78, no. 9, p. 2344-2360

    2023  , Page(s) 2344–2360

    Abstract: While both the incidence and general awareness of food allergies is increasing, the variety and clinical availability of therapeutics remain limited. Therefore, investigations into the potential factors contributing to the development of food allergy (FA) ...

    Abstract While both the incidence and general awareness of food allergies is increasing, the variety and clinical availability of therapeutics remain limited. Therefore, investigations into the potential factors contributing to the development of food allergy (FA) and the mechanisms of natural tolerance or induced desensitization are required. In addition, a detailed understanding of the pathophysiology of food allergies is needed to generate compelling, enduring, and safe treatment options. New findings regarding the contribution of barrier function, the effect of emollient interventions, mechanisms of allergen recognition, and the contributions of specific immune cell subsets through rodent models and human clinical studies provide novel insights. With the first approved treatment for peanut allergy, the clinical management of FA is evolving toward less intensive, alternative approaches involving fixed doses, lower maintenance dose targets, coadministration of biologicals, adjuvants, and tolerance‐inducing formulations. The ultimate goal is to improve immunotherapy and develop precision‐based medicine via risk phenotyping allowing optimal treatment for each food‐allergic patient.
    Keywords allergens ; food allergies ; humans ; immunotherapy ; medicine ; pathophysiology ; patients ; peanuts ; phenotype ; risk ; rodents
    Language English
    Dates of publication 2023-09
    Size p. 2344-2360
    Publishing place John Wiley & Sons, Ltd
    Document type Article ; Online
    Note REVIEW
    ZDB-ID 391933-x
    ISSN 1398-9995 ; 0105-4538
    ISSN (online) 1398-9995
    ISSN 0105-4538
    DOI 10.1111/all.15749
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  10. Article ; Online: Oral peanut immunotherapy How much is too much? How much is enough?

    Bluemchen, Katharina / Eiwegger, Thomas

    Allergy

    2018  Volume 74, Issue 2, Page(s) 220–222

    MeSH term(s) Arachis ; Child ; Desensitization, Immunologic ; Feasibility Studies ; Humans ; Peanut Hypersensitivity
    Language English
    Publishing date 2018-10-23
    Publishing country Denmark
    Document type Editorial ; Comment
    ZDB-ID 391933-x
    ISSN 1398-9995 ; 0105-4538
    ISSN (online) 1398-9995
    ISSN 0105-4538
    DOI 10.1111/all.13644
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top